Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 6
1964 1
1965 1
1966 2
1967 4
1968 2
1969 4
1970 7
1971 4
1972 2
1973 3
1974 2
1975 2
1976 5
1977 8
1978 4
1979 6
1980 6
1981 6
1982 16
1983 19
1984 5
1985 8
1986 17
1987 21
1988 19
1989 14
1990 16
1991 14
1992 21
1993 17
1994 12
1995 18
1996 29
1997 26
1998 32
1999 27
2000 24
2001 26
2002 24
2003 35
2004 36
2005 41
2006 43
2007 45
2008 55
2009 47
2010 30
2011 29
2012 28
2013 34
2014 40
2015 34
2016 47
2017 52
2018 46
2019 54
2020 63
2021 65
2022 67
Text availability
Article attribute
Article type
Publication date

Search Results

1,283 results
Results by year
Filters applied: . Clear all
Page 1
Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.
Takahashi H, Nomura H, Iriki H, Kubo A, Isami K, Mikami Y, Mukai M, Sasaki T, Yamagami J, Kudoh J, Ito H, Kamata A, Kurebayashi Y, Yoshida H, Yoshimura A, Sun HW, Suematsu M, O'Shea JJ, Kanno Y, Amagai M. Takahashi H, et al. Among authors: kubo a. Sci Immunol. 2021 Oct 15;6(64):eabb6444. doi: 10.1126/sciimmunol.abb6444. Epub 2021 Oct 8. Sci Immunol. 2021. PMID: 34623903
Phakomatosis Pigmentokeratotica.
Kubo A, Yamada D. Kubo A, et al. N Engl J Med. 2019 Oct 10;381(15):1458. doi: 10.1056/NEJMicm1817155. N Engl J Med. 2019. PMID: 31597022 No abstract available.
The EcoCyc Database.
Karp PD, Weaver D, Paley S, Fulcher C, Kubo A, Kothari A, Krummenacker M, Subhraveti P, Weerasinghe D, Gama-Castro S, Huerta AM, Muñiz-Rascado L, Bonavides-Martinez C, Weiss V, Peralta-Gil M, Santos-Zavaleta A, Schröder I, Mackie A, Gunsalus R, Collado-Vides J, Keseler IM, Paulsen I. Karp PD, et al. Among authors: kubo a. EcoSal Plus. 2014 May;6(1):10.1128/ecosalplus.ESP-0009-2013. doi: 10.1128/ecosalplus.ESP-0009-2013. EcoSal Plus. 2014. PMID: 26442933 Free PMC article.
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Sho T, Suda G, Ogawa K, Kimura M, Kubo A, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Shigesawa T, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Yamamoto Y, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Miyagishima T, Sakamoto N. Sho T, et al. Among authors: kubo a. Hepatol Res. 2021 Sep;51(9):979-989. doi: 10.1111/hepr.13693. Epub 2021 Jul 20. Hepatol Res. 2021. PMID: 34245216
Pathophysiological mechanisms of persistent orofacial pain.
Shinoda M, Hayashi Y, Kubo A, Iwata K. Shinoda M, et al. Among authors: kubo a. J Oral Sci. 2020 Mar 28;62(2):131-135. doi: 10.2334/josnusd.19-0373. Epub 2020 Mar 4. J Oral Sci. 2020. PMID: 32132329 Free article.
Familial acanthosis nigricans with p.K650T FGFR3 mutation.
Fukuchi K, Tatsuno K, Matsushita K, Kubo A, Ito T, Tokura Y. Fukuchi K, et al. Among authors: kubo a. J Dermatol. 2018 Feb;45(2):207-210. doi: 10.1111/1346-8138.14107. Epub 2017 Oct 25. J Dermatol. 2018. PMID: 29068064 Review.
Japanese guidelines for the management of palmoplantar keratoderma.
Yoneda K, Kubo A, Nomura T, Ishida-Yamamoto A, Suga Y, Akiyama M, Kanazawa N, Hashimoto T; Committee on Guidelines for the Management of PPKs. Yoneda K, et al. Among authors: kubo a. J Dermatol. 2021 Aug;48(8):e353-e367. doi: 10.1111/1346-8138.15850. Epub 2021 Jun 13. J Dermatol. 2021. PMID: 34121213
1,283 results